Breaks Categories: Stock Spotlights

FridayFeb 16, 2018 9:24 am

CannabisNewsBreaks – Why Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is engaged in acquiring and developing a strategic portfolio of companies that also believe in the substantial potential of the industrial hemp plant. An article discussing the company reads: “The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) (https://globalhempgroup.com/hempagro/) in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global…

Continue Reading

ThursdayFeb 15, 2018 3:10 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Utilizes Oral Digestion Technology to Expand Product Line

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently announced its entry into a licensing agreement with Cannfections Group Inc. The agreement offers Lexaria the ability to provide commercial clients with high quality chocolate edibles using its proprietary DehydraTECH™ oral digestion technology. An article discussing the company reads: “Lexaria has developed various products for demonstration, testing and sales, showing wide applicability. These non-psychoactive cannabinoid products have a high-absorption hemp oil formula, are an excellent source of omegas and essential fatty acids and are engineered for physiological performance and recovery. APIs within Lexaria’s products have been shown to reduce anxiety and stress while…

Continue Reading

ThursdayFeb 15, 2018 11:18 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Eyes Bright Future

The Green Organic Dutchman Holdings Ltd., also known as TGOD, remains confident that its commitment to its core values coupled with its unique approach to producing high quality, pharma-grade cannabis creates opportunities for the company, including potential joint ventures, licensing agreements and distribution partnerships. An article discussing the company’s bright future reads: “TGOD is setting the industry standard on several fronts, including environmental stewardship, natural resource sustainability and development of a consortium of world-class architectural, construction and utility management teams dedicated to responsible practices. As a Canadian licensed cannabis producer, TGOD prides itself on growing completely organic, pesticide-free, grown-in-live-soil cannabis.…

Continue Reading

FridayFeb 09, 2018 12:53 pm

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (PVOTF) Working on Delivery of Smokeless Cannabinoid Options

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) is focused on providing the health care marketplace with nutraceutical and pharmaceutical options for treating certain unmet needs. That extends to the medical cannabis industry, where the lack of a robust smokeless delivery system has troubled cannabinoid producers. An article discussing this reads: "Transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects. Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in…

Continue Reading

FridayFeb 09, 2018 9:46 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Secures Financing Boost for Cannabis Facilities Expansion

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, has benefited from strategic investments by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) and other private placement financing, with its total financing climbing to $160 million. The Aurora investment in TGOD is accompanied by a supply agreement providing Aurora the right to purchase up to 20 percent of TGOD’s annual production of organic cannabis, and TGOD will receive additional services from Aurora and its subsidiary, Aurora Larssen Projects Inc. ("ALPS"). An article discussing this reads: “The investment fully funds the expansion of…

Continue Reading

TuesdayFeb 06, 2018 11:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement to Create Cannabis-infused Edibles Utilizing DehydraTECH™ Delivery Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently entered an agreement with a cannabis-infused edibles manufacturer, Cannfections Group Inc. The agreement is expected to generate new cannabis-based edible products using Lexaria’s patented DehydraTECH™ delivery technology. An article discussing the agreement reads: “On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://cnw.fm/3oV1q). Cannfections is a new company, established by one of Canada’s leading chocolate manufacturers with over 85 years…

Continue Reading

MondayJan 29, 2018 11:38 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates. The company has been working with the National Research Council of Canada (“NRC”), an agency of the Canadian federal government, to explore the effects of its technology. Lexaria’s superior delivery system…

Continue Reading

FridayJan 26, 2018 2:31 pm

CannabisNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Aims to Multiply Production Capabilities in 2018

Premium cannabis lifestyle brand DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) is a licensed marijuana producer under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The company recently expanded its production capacity through the acquisition of a new warehouse. A recent article discussing the company reads: “As a licensed cannabis producer under the ACMPR through its wholly-owned subsidiary Northern Lights Marijuana Company, DOJA currently operates a 7,100-square-foot production facility that is licensed by Health Canada. The company recently acquired second facility is a 22,580-square-foot warehouse where its FUTURE LAB will be housed. The FUTURE LAB will be a state-of-the-art…

Continue Reading

WednesdayJan 24, 2018 11:26 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Enhances Life by Uniting Nature and Science

An ongoing concern in North America, as reported by the Centers for Disease Control and Prevention, is that Americans are only taking advantage of preventive medical services about half as often as they should. Endeavoring to become a pioneer in preventative medicine, health science company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was founded on the belief that, in healthcare, prevention is the best policy, and that nature and science can unite to offer a range of innovative, untapped solutions to address unmet clinical needs. As quoted in a recent article: “PreveCeutical is taking a new look at…

Continue Reading

WednesdayJan 24, 2018 11:19 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Platform Expands Portfolio

Food bioscience company Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) strategic focus for 2018 is on out-licensing its proprietary technology, DehydraTECH™. The company intends to out-license to third-party partners using a high margin royalty model. An article discussing the company’s drug delivery platform reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million Insights (http://cnw.fm/fGid9), the global API market is anticipated to reach $239.8 billion by 2025, with…

Continue Reading